JOHNSON & JOHNSON's most recent trades

10% Owner

%

COMPANY

SHARES

NET TOTAL

37.77%

Fate Therapeutics, Inc.

3,379,064

$83,733,000.00

20.02%

Arrowhead Pharmaceuticals, Inc.

1,260,869

$44,395,000.00

9.90%

MeiraGTx Holdings plc

2,898,550

$21,942,000.00

9.23%

748,062

$20,474,000.00

8.74%

Protagonist Therapeutics Inc.

2,449,183

$19,373,000.00

4.80%

Adicet Bio, Inc.

728,944

$10,643,000.00

4.12%

Fusion Pharmaceuticals Inc.

3,670,516

$9,140,000.00

2.41%

Vor Biopharma, Inc.

1,074,658

$5,341,000.00

0.98%

Nano-X Imaging Ltd.

192,429

$2,174,000.00

0.71%

Aldeyra Therapeutics, Inc.

394,834

$1,575,000.00

0.70%

2,133,402

$1,557,000.00

0.43%

PhaseBio Pharmaceuticals, Inc.

1,607,044

$964,000.00

0.08%

Tracon Pharmaceuticals, Inc.

84,003

$168,000.00

0.05%

Catalyst Biosciences, Inc.

66,951

$119,000.00

0.03%

Senseonics Holdings, Inc.

54,621

$56,000.00

0.02%

Graybug Vision, Inc.

49,547

$54,000.00